The Scientist

» clinical trials, disease/medicine and ecology

Most Recent

image: Infographic: Repurposing Strategies

Infographic: Repurposing Strategies

By | January 1, 2017

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

0 Comments

image: Cheetah Range Drops 90 Percent

Cheetah Range Drops 90 Percent

By | December 27, 2016

Estimating only 7,100 individuals remaining, researchers urge a reclassification of the species from vulnerable to endangered.

0 Comments

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.

1 Comment

image: FDA OKs Clinical Trials of Ecstasy for PTSD

FDA OKs Clinical Trials of Ecstasy for PTSD

By | December 1, 2016

The illicit drug has shown promise in helping people with debilitating post-traumatic stress disorder.

0 Comments

image: Elephant Footprints Create Habitat for Tiny Aquatic Creatures

Elephant Footprints Create Habitat for Tiny Aquatic Creatures

By | December 1, 2016

Researchers discover diverse communities of invertebrates inhabiting the water-filled tracks of elephants in Uganda.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

image: Opinion: Not All Genetic Databases Are Equal

Opinion: Not All Genetic Databases Are Equal

By | December 1, 2016

Sorting out which data sets are clinical-grade is key to helping patients.

0 Comments

image: More Success Fixing Sickle Cell Gene with CRISPR

More Success Fixing Sickle Cell Gene with CRISPR

By | November 9, 2016

Researchers say they have sufficient in vitro and animal data to apply for human testing.

0 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

Popular Now

  1. National Academies Detail the State of Weed Science
  2. Neural Mechanism Links Alcohol Consumption to Binge Eating
  3. Image of the Day: Monkey Business
    Image of the Day Image of the Day: Monkey Business

    For the first time, researchers have documented interspecies sexual behavior between a male Japanese macaque and a female sika deer.

  4. Trumping Science: Part III
    The Nutshell Trumping Science: Part III

    Scientists criticize unconfirmed reports that President-elect Donald Trump has asked Robert Kennedy Jr., an anti-vaccine activist, to investigate vaccine safety.

RayBiotech